Skip to main content

Vimseltinib (DCC-3014) MOTION

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Deciphera Pharmaceuticals, LLC

Start Date

March 16, 2022

End Date

January 26, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Deciphera Pharmaceuticals, LLC

Start Date

March 16, 2022

End Date

January 26, 2023